MISSELWITZ FRANK,KUBITZA DAGMAR,PARK SON-MI,WEHLING KLAUS,MISSELWITZ Frank,KUBITZA Dagmar,PARK Son-Mi,WEHLING Klaus
申请号：
SI200631948
公开号：
SI1845961T1
申请日:
2006.01.19
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
